Boulla recalls
Boulla appears in 4 official U.S. recall notices indexed by RecallRadar, most recently on 2024-12-11.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 4 |
|---|---|
| Published | 2024-12-11 |
| By agency | FDA Drug (4) |
| By classification | Class I (4) |
| By status | ongoing (4) |
| Distribution named in notices | US |
Recalls
- ZoomMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZoomMax, 2108 N St. Sacramento, CA 95816, www.zoommax.com
FDA Drug · Class I · 2024-12-11 · Boulla
Reason: Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac. - VitalityXtra Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: VitalityXtra, San Francisco, CA www.vitalityxtra.c…
FDA Drug · Class I · 2024-12-11 · Boulla
Reason: Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac. - ZapMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZapMax, 2108 N St. Sacramento, CA 95816, www.zapmax.com
FDA Drug · Class I · 2024-12-11 · Boulla
Reason: Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac. - PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com
FDA Drug · Class I · 2024-12-11 · Boulla
Reason: Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.